Status: Not yet recruiting
Study to Evaluate LPH-5 in Healthy Subjects
This study will explore the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of LPH-5.
Participants needed: 48
Trial details
Phase: Phase 1Age: 18-65Biological sex: MaleType: InterventionalSponsor: LophoraUpdated: Dec 9, 2024
Eligibility criteria
Healthy as determined by a responsible physician, based on medical evaluation in...
Any condition or disease detected during the medical interview/physical examinat... [+2]